Evidence map›Paper›PMID 39931441›Full record

ArticleChina CDC weekly2025

Respiratory Pathogen Profiles of Patients - Beijing Municipality, China, November 2023-April 2024.

Han Du, Jun Li, Haoyu Wen, Zhixia Gu, Yufei Chang, Wenwan Rong, Zhuo Yang, Rahat Ullah Khan, Zhaomin Feng, Quanyi Wang and 2 more

Abstract read
In one paragraph

Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Post-pandemic resurgence and collapse ofFrontiers in public health · 2026
    Article
  3. Article
  4. Article
  5. A comparison of diagnostic and therapeutic approaches for Mycoplasma pneumoniae pneumonia in children and adults, during the post-COVID-19 pandemic era.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Han DuCollege of Life Science and Technology, Xinjiang University, Urumchi City, Xinjiang Uygur Autonomous Region, China.
Jun LiBeijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing, China.
Haoyu WenCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning, CAS-TWAS Center of Excellence for Emerging Infectious Diseases, Chinese Academy of Sciences, Beijing, China.
Zhixia GuBeijing Ditan Hospital, Capital Medical University, Beijing, China.
Yufei ChangBeijing Ditan Hospital, Capital Medical University, Beijing, China.
Wenwan RongCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning, CAS-TWAS Center of Excellence for Emerging Infectious Diseases, Chinese Academy of Sciences, Beijing, China.
Zhuo YangBeijing Ditan Hospital, Capital Medical University, Beijing, China.
Rahat Ullah KhanCAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning, CAS-TWAS Center of Excellence for Emerging Infectious Diseases, Chinese Academy of Sciences, Beijing, China.
Zhaomin FengBeijing Research Center for Respiratory Infectious Diseases, Beijing Center for Disease Prevention and Control, Beijing, China.
Quanyi WangBeijing Research Center for Respiratory Infectious Diseases, Beijing Center for Disease Prevention and Control, Beijing, China.
Rui SongBeijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing, China.
Yuhai BiCollege of Life Science and Technology, Xinjiang University, Urumchi City, Xinjiang Uygur Autonomous Region, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Respiratory pathogens pose a complex challenge for public health systems. In the winter of 2023, multiple respiratory pathogens showed staggered epidemic waves. Additionally, co-infections involving various pathogens were observed, resulting in significant disease burdens. Understanding the epidemiological dynamics of these pathogens is essential for supporting public health systems in the prevention and control of respiratory infectious diseases. Methods: Respiratory samples were collected from patients in Beijing presenting with influenza-like symptoms to detect 27 respiratory pathogens using multiplex qPCR. Results: Four distinct epidemic waves were identified. The first wave was a pre-winter outbreak of Conclusions: Respiratory pathogens exhibited different prevalence trends during the first influenza season following the COVID-19 pandemic. Influenza viruses showed a higher peak incidence and delayed seasonality. Moreover, the co-circulation of viral and bacterial infections increased the complexity of respiratory infections. Interestingly, staggered epidemic waves between SARS-CoV-2 and influenza A/B viruses were observed. Consequently, SARS-CoV-2 may become a seasonal virus, causing epidemics alongside influenza viruses. However, further research is needed to elucidate its epidemiological patterns. The co-circulation of these epidemic viruses and other respiratory pathogens underscores the need for enhanced diagnostic and intervention strategies, including vaccination campaigns.

Indexed as

BacteriaPost-COVID-19 eraRespiratory pathogenVirus

Identifiers

PMID39931441
PMCPMC11807245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.